Publicaciones en colaboración con investigadores/as de Hospital del Bierzo (71)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  2. Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study

    Clinical Drug Investigation

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

2022

  1. Development and validation of a questionnaire for assessing patients´ perceptions of interprofessional integration in health care

    Journal of Interprofessional Care, Vol. 36, Núm. 4, pp. 538-544

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

  4. TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features

    American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914

2021

  1. Clinical and biological markers for predicting ARDS and outcome in septic patients

    Scientific Reports, Vol. 11, Núm. 1

  2. Effect of the type of specialized nutrition support on the course of the patient with amyotrophic lateral sclerosis (ALS). Interhospital registry SCLEDyN

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 10, pp. 699-707

  3. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  4. Impact of percutaneous endoscopic gastrostomy (Peg) on the evolution of disease in patients with amyotrophic lateral sclerosis (als)

    Nutrients, Vol. 13, Núm. 8

  5. Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID)

    Wiener klinische Wochenschrift, Vol. 133, Núm. 7-8, pp. 303-311

  6. Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 6, pp. 413-420

  7. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407

  2. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey

    Rheumatology International, Vol. 40, Núm. 2, pp. 303-311

  3. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

    European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270

2019

  1. Does my patient really need this at admission? Seven opportunities for improving value in patient care during their hospitalization

    European Journal of Internal Medicine, Vol. 66, pp. 92-98

  2. Epidemiology and Changes in Mortality of Sepsis After the Implementation of Surviving Sepsis Campaign Guidelines

    Journal of Intensive Care Medicine, Vol. 34, Núm. 9, pp. 740-750